Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yasser Khazaal, Lausanne university, Switzerland

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist and researcher with extensive experience in addiction psychiatry. He earned his MD from René Descartes, Paris V, and Swiss Board Certification in Psychiatry and Psychotherapy. Currently, he is a Full Professor at the University of Lausanne, Switzerland, and holds multiple roles including Associate Researcher at Montreal University. Prof. Khazaal’s research focuses on cognitive behavioral therapies, game-based interventions, and the development of smartphone apps for addiction treatment. He has published extensively on addictive disorders and is a key figure in international psychiatric societies. 🏥📚🔬

Publication Profile

google scholar

Education

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist with an impressive academic background. He earned his MD from René Descartes, Paris V, France, in 1998. In 2005, he achieved Swiss Board Certification in Psychiatry and Psychotherapy. His expertise and contributions were further recognized with his appointment as a Privat Docent (senior lecturer) at Geneva University in 2009. Dr. Khazaal is known for his work in psychiatry and psychotherapy, holding a prominent position in the academic and clinical communities in Switzerland. 🌐🩺📚

Employment History

Prof. Dr. Yasser Khazaal has an extensive background in addiction psychiatry. From 2003 to 2005, he served as a senior psychiatrist and head of the mood and anxiety disorders outpatient unit at Lausanne University Hospital. From 2007 to 2018, he was the deputy head of the Addiction clinic at Geneva University Hospitals. Over the years, he held successive academic appointments at Geneva University, Switzerland, eventually becoming a full professor of addiction psychiatry at the Faculty of Biology and Medicine, University of Lausanne since 2019. He is also a member of the board of Addiction medicine at Lausanne University Hospital. Prof. Khazaal is an associate researcher at the Montreal University Institute of Mental Health, Canada, and an associate professor at the Department of Psychiatry and Addiction, Montreal University, Canada. Additionally, he served as a visiting professor at Kazimierz Wielki University, Poland, in 2022, as part of a project co-financed by the European Union. 📘🔍🌍

Teaching

Prof. Dr. Yasser Khazaal has extensive experience in teaching medical students at both the University of Lausanne (2003-2007, 2019-2023) and the University of Geneva (2007-2018). His teaching portfolio includes courses on mood and anxiety disorders (2003-2007), psychopharmacology (2006-2007), addiction (2019-2023), and community research in practice (2021-2023). He has also taught and supervised clinical cognitive and behavior therapy (CBT) skills (2018-2023), CBT for bipolar disorder (2007), CBT for mood disorders (2005-2006), and CBT of impulsive behaviors (2020). Prof. Dr. Khazaal is committed to integrating clinical teaching and practice in his courses. 📚💬🧠

Grants 

Prof. Dr. Yasser Khazaal is a leading researcher in addiction and mental health, with extensive funding from various Swiss and international sources. His projects include studies on cognitive behavioral interventions for psychosis, mood and anxiety disorders, smoking cessation, and smartphone applications for addiction treatment. Key grants include the Swiss National Science Foundation (268,426 CHF) and Astra-Zeneca (140,000 CHF) for LACOSMA, as well as research on “Impact of Pick Klop game on smoking cessation” (172,500 CHF) and smartphone applications (194,942 CHF). He collaborates internationally on projects such as managing trauma exposure in Congo (12,125 Euros) and the “Sesame” serious game for mental health (20,000 CHF). His work continues to advance the field with a focus on innovative and practical solutions to addiction and mental health challenges. 🧠💊🚬

Conferences and Awards

Prof. Dr. Yasser Khazaal is a distinguished academic and leader in the field of social psychiatry. He served as the Chair for the European Congress of Social Psychiatry in 2012, 2015, and 2018. He was also the Co-chair for the International Conference of Behavioral Addictions in 2016, held in Geneva, Switzerland. More recently, he co-chaired the Challenges of Ecology Related to Mental Health conference in Athens in 2022. In recognition of his contributions, he was elected an Honorary Fellow of the World Association of Social Psychiatry in 2013. 🌍🔍💬

Scientific Achievements

Prof. Dr. Yasser Khazaal is a renowned expert in addiction studies, focusing on game-based interventions, including delusions and smoking cessation. He has contributed significantly to the development of smartphone app interventions for addictive disorders and mood regulation. Prof. Khazaal has published extensively on the assessment and psychopathology of addictive disorders. He also leads research on Recovery Oriented Services, exploring community interventions and peer support initiatives. 🌱📱🚭📚

Research Focus

Yasser Khazaal is a researcher primarily focused on behavioral addictions, particularly in the context of online gaming and internet use. His work explores how common behaviors can become problematic without necessarily being pathologized as addiction. He investigates self-reported motivations behind playing online games, such as World of Warcraft, and examines problematic involvement in these games using various psychological and survey methods. Khazaal’s research aims to refine the understanding of behavioral addiction and its implications for mental health, with a particular interest in the validation and adaptation of assessment tools for addictive behaviors in digital environments. 💻🕹️📊

Publication Top notes

Are we overpathologizing everyday life? A tenable blueprint for behavioral addiction research

How can we conceptualize behavioural addiction without pathologizing common behaviours?

Why do you play World of Warcraft? An in-depth exploration of self-reported motivations to play online and in-game behaviours in the virtual world of Azeroth

French validation of the internet addiction test

Validation of a short French version of the UPPS-P Impulsive Behavior Scale

Problematic involvement in online games: A cluster analytic approach

Does self-selection affect samples’ representativeness in online surveys? An investigation in online video game research

Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey

 

 

 

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Panagiotis Liakos, Faculty of Medicine, University of Thessaly, Greece

Prof. Dr. Panagiotis Liakos is an esteemed biochemist and researcher specializing in cellular biochemistry and hypoxia-related cancer mechanisms. He earned his Maîtrise, Master’s, and Ph.D. in Molecular and Cellular Biology from Joseph Fourier I University, France. His postdoctoral work at Aristotle University in Greece laid the foundation for his academic career, leading him to his current role as Professor and Director of the Department of Basic and Applied Biomedical Sciences at the University of Thessaly. His research focuses on hypoxia-inducible factors (HIFs), particularly HIF-2α, exploring its role in cancer and angiogenesis. 🧬👨‍🔬📚

Publication Profile

google scholar

Education 

Prof. Dr. Panagiotis Liakos is a distinguished biochemist with a career spanning from Grenoble to Greece. He completed a Maîtrise in Biochemistry (1994) and a Master’s in Molecular and Cellular Biology (1995) at Joseph Fourier I University, France, followed by a PhD (1999) in Biochemistry and Cellular Endocrine Regulation. His postdoctoral research was conducted at Aristotle University Thessaloniki. In 2003, he became a Lecturer at the University of Thessaly, advancing to Professor in 2022. Currently, he leads the Department of Basic and Applied Biomedical Sciences. His clinical expertise includes years at Larissa University Hospital. 🌍🔬📚👨‍🔬💼

Research Project

Prof. Dr. Panagiotis Liakos has significantly contributed to pioneering health research. Highlights include leading the French Ministry of Health’s 1994 Breast Cancer Prevention program, advancing studies on ACTH receptor expression in adrenal glands (1995-1998), and collaborating on a French-Portuguese program to analyze steroidogenic enzymes in rats and adrenal carcinomas. Furthering adrenal cancer research, he partnered with the Fondation pour la Recherche Médicale (1998-1999). Dr. Liakos explored metalloproteases in skin pathophysiology in a Greek program (2001-2003) and obesity rates in Thessaly (2005-06). His work on signaling pathways under hypoxic stress enriches endocrine research. 🧬🔬

Experience

Prof. Dr. Panagiotis Liakos has been a dedicated educator and coordinator in molecular biology, genetics, and biochemistry since 2001. He taught Biochemistry I & II and Clinical Biochemistry at Democritus University of Thrace, later joining the University of Thessaly to instruct Molecular Biology, Metabolism Regulation, and various biochemistry courses. Since 2004, he has led the Clinical Biochemistry course for medical students and coordinated the Cellular Signaling course in molecular medicine. His teaching repertoire includes postgraduate courses on reproduction genetics, human genetics, and balanced nutrition. Prof. Liakos’s commitment to education spans two decades, fostering expertise in health sciences. 📘🧬👨‍🏫✨

Honors

Prof. Dr. Panagiotis Liakos has been recognized internationally for his research achievements, receiving prestigious scholarships and fellowships from the French Ministry of Research and Fondation pour la Recherche Médicale. These honors underscore his dedication and impactful contributions to his field, highlighting the global relevance of his work. Through these awards, Dr. Liakos has advanced his research, fostering significant progress and collaboration. His achievements not only emphasize his scientific expertise but also reflect his commitment to excellence in research and innovation. 🌍📚🔬

Research Focus

Prof. Dr. Panagiotis Liakos specializes in cellular and molecular biology, particularly focusing on hypoxia and its effects on cellular processes. His research explores how hypoxia-inducible factors (HIFs), especially HIF-1 and HIF-2, regulate gene expression under low-oxygen conditions and influence cancer progression, lipid metabolism, and viral replication. Dr. Liakos’s work also examines the effects of oxidative stress and signaling pathways like PI-3K and MAPK on cellular adaptation to hypoxic stress. His contributions are significant in understanding hypoxia’s role in disease states such as cancer and liver disease, and its broader implications for therapeutic development. 🧬🩺🔬🌬️📊

Publication Top Notes

Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression

Cobalt induces hypoxia-inducible factor-1α (HIF-1α) in HeLa cells by an iron-independent, but ROS-, PI-3K-and MAPK-dependent mechanism

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

The role of hypoxia‐inducible factor‐2 alpha in angiogenesis

Cushing’s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis

Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells